Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Arcellx, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 138 | 1 | 136 | −1 |
| Shares | 48.1M | 556.4K | 47.6M | +58.8K (+0.1%) |
| Value | $1.52B | $17.6M | $1.71B | +$204.8M (+13.6%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Arcellx, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 910,178 | $32.7M | 0.02% |
| Pictet Asset Management Holding SA | 388,120 | $13.9M | 0.02% |
| Caas Capital Management LP | 124,959 | $4.48M | 1.00% |
| Healthcare of Ontario Pension Plan Trust Fund | 64,000 | $2.30M | 0.01% |
| ExodusPoint Capital Management, LP | 37,952 | $1.36M | 0.02% |
| MYDA Advisors LLC | 25,000 | $897.0K | 0.34% |
| HRT Financial LP | 21,015 | $754.0K | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 19,364 | $694.8K | 0.00% |
| Gsa Capital Partners LLP | 18,304 | $657.0K | 0.06% |
| SG Americas Securities, LLC | 17,067 | $612.0K | 0.01% |
| Endurant Capital Management LP | 14,158 | $508.0K | 0.46% |
| Corton Capital Inc. | 7,533 | $270.3K | 0.14% |
| LPL Financial LLC | 6,783 | $243.4K | 0.00% |
| High Net Worth Advisory Group LLC | 6,500 | $233.2K | 0.09% |
| Bayesian Capital Management, LP | 6,100 | $218.9K | 0.02% |
| Comerica Bank | 119 | $4.27K | 0.00% |
| Simplex Trading, LLC | 9 | $0 | 0.00% |
Sold out (18)
Institutions that held Arcellx, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Logos Global Management LP | 500,000 | $15.8M |
| Qube Research & Technologies Ltd | 110,744 | $3.50M |
| Cubist Systematic Strategies, LLC | 108,589 | $3.43M |
| Sphera Funds Management Ltd. | 77,488 | $2.45M |
| EAM Investors, LLC | 55,714 | $1.76M |
| Squarepoint Ops LLC | 39,295 | $1.24M |
| Twinbeech Capital LP | 32,668 | $1.03M |
| Jump Financial, LLC | 26,796 | $847.3K |
| Adams Street Partners LLC | 22,924 | $724.9K |
| Aigen Investment Management, LP | 20,564 | $650.2K |
| D. E. Shaw & Co., Inc. | 20,210 | $639.0K |
| SEI Investments Co | 10,941 | $346.0K |
| Citizens Financial Group Inc | 9,402 | $297.3K |
| Point72 Middle East FZE | 8,752 | $276.7K |
| Acadian Asset Management LLC | 1,811 | $57.0K |
| Genworth Financial Inc | 1,791 | $56.6K |
| Group One Trading, L.P. | 263 | $8.32K |
| Allspring Global Investments Holdings, LLC | 150 | $4.74K |
Not filed for Q3 2023 yet (1)
Institutions that held Arcellx, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 556,408 | $17.6M |